Pharmacokinetics Study of Liposomal Paclitaxel in Humans

PHASE4CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Cancer
Interventions
DRUG

Liposomal paclitaxel

Patients will be given Liposomal paclitaxel intravenously in 3 hours with the dose of 175mg/m2 at the first day of chemotherapy. Cycle duration will be 21 days. Each patient will receive 3 cycles of therapy.

DRUG

Paclitaxel

Patients will be given paclitaxel intravenously in 3 hours with the dose of 175mg/m2 at the first day of chemotherapy. Cycle duration will be 21 days. Each patient will receive 3 cycles of therapy.

Trial Locations (2)

200032

Cancer Hospital of Fudan University, Shanghai

Cancer Hospital of Fudan University, Shanghai

Sponsors
All Listed Sponsors
collaborator

Nanjing Sike Pharmaceutical Co., Ltd.

INDUSTRY

lead

Shandong Luye Pharmaceutical Co., Ltd.

INDUSTRY